Xu Jiandong

Xu Jiandong is listed in filings as Chief Financial Officer at Estrella Immunopharma, Inc.. This profile follows SEC Form 4 activity through Apr 29, 2026, including purchase activity. Recent filings connect the profile to Estrella Immunopharma, Inc. (ESLA). The current snapshot covers public activity from Feb 14, 2025 to Apr 29, 2026. Reported amounts are shown as $1.3K to $104. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.